跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IRITEC CONCENTRATE FOR SOLUTION FOR INFUSION 40mg/2ml - HSA Drug Approval Details
Approvals
/
HSA
/
IRITEC CONCENTRATE FOR SOLUTION FOR INFUSION 40mg/2ml
Approved
STANDARD
IRITEC CONCENTRATE FOR SOLUTION FOR INFUSION 40mg/2ml
Unknown
🇸🇬 Health Sciences Authority
Approval Date
Jan 13, 2026
Approval ID
73cbce9791a2248d
Company
Unknown
Type
Standard
Approval Details
Approval Id
73cbce9791a2248d
Drug Name
IRITEC CONCENTRATE FOR SOLUTION FOR INFUSION 40mg/2ml
Active Ingredients
Irinotecan Hydrochloride Trihydrate equ to Irinotecan34.66mg/vial
40mg/vial
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 13, 2026
Approval ID
73cbce9791a2248d
Type
Standard
Back to HSA Approvals
